ATLANTA (AP) — Federal authorities say they are working with Tennessee officials to investigate why at least 12 patients in that state who injected the pain reliever Opana ER for non-medical reasons since February have a rare blood disorder.
The Centers for Disease Control and Prevention issued the health advisory Friday night regarding the pain reliever, an extended-release form of oxymorphone. The CDC is working with the Food and Drug Administration and the Tennessee Department of Health.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.